- Stocks
- Pharma & Healthcare
- Kovai Medical Center & Hospital
Kovai Medical Center & Hospital share price
NSE: KOVAIPharma & HealthcareMedical Care Facilities
Kovai Medical Center & Hospital at a glance
Kovai Medical Center & Hospital (NSE: KOVAI) closed at ₹5,738.00 on 22 Oct 2026, down 2.24% on the day. With a market capitalisation of ₹6,279 Cr, it ranks 699th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
At its last close the stock traded at 25.7× trailing earnings, against a return on equity of 20.1% in FY18. Over the past year the share price has risen 190.4%. Its 52-week range is ₹5,275.50 (27 May 2026) to ₹6,444.00 (10 Sep 2026); the last close is 11.0% below the high. Promoters held 56.52% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹6,279 CrRank 699 on NSE
- P/E (trailing)
- 25.7×
- Price to book
- 4.74×FY18
- ROE
- 20.1%FY18
- ROCE
- 11.6%FY18
- Debt to equity
- 0.57FY18
- Net profit margin
- 9.8%FY18
- Book value / share
- ₹263.71FY18
- Dividend payout
- 5.7%FY18
- 52-week high
- ₹6,444.0010 Sep 2026
- 52-week low
- ₹5,275.5027 May 2026
- 1-year return
- +190.4%
- RSI (14-day)
- 33.6
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −2.24% | −4.2% | −7.3% | −1.6% | +190.4% |
Kovai Medical Center & Hospital financials
| Item | FY13 | FY14 | FY15 | FY16 | FY17 | FY18 |
|---|---|---|---|---|---|---|
| Revenue | ₹297 Cr | ₹334 Cr | ₹402 Cr | ₹465 Cr | ₹531 Cr | ₹592 Cr |
| Operating profit | ₹31 Cr | ₹37 Cr | ₹59 Cr | ₹62 Cr | ₹92 Cr | ₹89 Cr |
| Net profit | ₹20 Cr | ₹24 Cr | ₹39 Cr | ₹41 Cr | ₹60 Cr | ₹58 Cr |
| EPS (₹) | ₹19.00 | ₹22.00 | ₹35.00 | ₹37.00 | ₹55.00 | ₹53.00 |
| Cash from operations | ₹62 Cr | ₹68 Cr | ₹97 Cr | ₹85 Cr | ₹99 Cr | ₹87 Cr |
| Total debt | ₹179 Cr | ₹154 Cr | ₹128 Cr | ₹121 Cr | ₹86 Cr | ₹165 Cr |
| Shareholders' equity | ₹79 Cr | ₹101 Cr | ₹137 Cr | ₹174 Cr | ₹234 Cr | ₹289 Cr |
Kovai Medical Center & Hospital shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 56.55% | 56.55% | 56.52% | 56.52% | 56.52% | 56.52% |
| Foreign institutions | 1.10% | 1.28% | 1.24% | 1.31% | 1.20% | 1.25% |
| Domestic institutions | 4.03% | 4.52% | 4.90% | 4.73% | 4.48% | 4.25% |
| Non-institutions | 38.32% | 37.65% | 37.34% | 37.44% | 37.80% | 37.98% |
Kovai Medical Center & Hospital vs peers
The listed Pharma & Healthcare companies nearest to Kovai Medical Center & Hospital by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| MOREPENLABMorepen Laboratories | ₹125.70 | +5.63% | +141.6% | ₹6,888 Cr | 72.7 | — |
| SUPRIYASupriya Lifescience | ₹848.80 | −0.02% | +19.4% | ₹6,831 Cr | 32.7 | — |
| BLISSGVSBliss GVS Pharma | ₹638.00 | +2.42% | +319.4% | ₹6,766 Cr | 53.1 | — |
| SANOFISanofi India | ₹2,845.00 | +0.53% | −40.0% | ₹6,552 Cr | 21.2 | — |
| ENTEROEntero Healthcare Solutions | ₹1,504.20 | −0.19% | +36.0% | ₹6,547 Cr | 57.1 | — |
| KOVAIKovai Medical Center & Hospital | ₹5,738.00 | −2.24% | +190.4% | ₹6,279 Cr | 25.7 | — |
| NEPHROPLUSNephrocare Health Services | ₹599.90 | −0.84% | — | ₹6,019 Cr | 74.1 | — |
Ask anything about Kovai Medical Center & Hospital
Pivot answers on the live chart with evidence you can check, and tests strategies against KOVAI's own history. Try: “Why has KOVAI moved over the last three months?” · “Backtest a 50-day moving-average crossover on KOVAI over five years” · “Compare KOVAI with MOREPENLAB on margins and valuation”
Frequently asked questions about Kovai Medical Center & Hospital
What is the share price of Kovai Medical Center & Hospital today?
Kovai Medical Center & Hospital (NSE: KOVAI) last closed at ₹5,738.00 on 22 Oct 2026. Its 52-week high is ₹6,444.00 and its 52-week low is ₹5,275.50.
What is the market cap of Kovai Medical Center & Hospital?
Kovai Medical Center & Hospital's market capitalisation is ₹6,279 Cr (₹6,279 Cr) at the 22 Oct 2026 close, ranking 699th among the NSE companies Pivot tracks.
What is the P/E ratio of Kovai Medical Center & Hospital?
Kovai Medical Center & Hospital trades at a trailing P/E of 25.7. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 57.1.
What is the ROE and ROCE of Kovai Medical Center & Hospital?
Return on equity was 20.1% in FY18 and return on capital employed was 11.6% in FY18 (consolidated figures).
Is Kovai Medical Center & Hospital a debt-free company?
No. Kovai Medical Center & Hospital's debt-to-equity ratio was 0.57 in FY18, with total debt of ₹165 Cr.
How has Kovai Medical Center & Hospital stock performed over the last year?
Kovai Medical Center & Hospital's share price has risen 190.4% over the past year, −1.6% over three months and −7.3% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Kovai Medical Center & Hospital?
As of 30 Jun 2026: promoters 56.52%, foreign institutions 1.25%, domestic institutions 4.25%, non-institutions 37.98%.
Who are Kovai Medical Center & Hospital's competitors?
The listed Pharma & Healthcare companies closest to Kovai Medical Center & Hospital by market cap are Morepen Laboratories, Supriya Lifescience, Bliss GVS Pharma, Sanofi India, Entero Healthcare Solutions and Nephrocare Health Services.
Is Kovai Medical Center & Hospital a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Kovai Medical Center & Hospital's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KOVAI against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with K · all NSE stocks · this page as text